← Human Trials & Peer-Reviewed Studies

Peer-reviewed, evidence-based analysis of vitamin D and primary hyperparathyroidism.

Plain-language guide to PMID 19308641 (2009): review of Vitamin D, K2, Magnesium and Zinc, hyperparathyroidism.

Key Facts

PMID
19308641
Journal
World journal of surgery
Year
2009
Study type
Review
Authors
Weaver S et al. (4 authors)
DOI
10.1007/s00268-009-9966-9

What This Paper Covers, in Plain Language

What It Covers

This review looks at Vitamin D, K2, Magnesium and Zinc in the context of hyperparathyroidism.

Primary hyperparathyroidism (PHPT) is a disease of the endocrine system that can result in debility if not diagnosed.

New understanding about the effect of vitamin D on parathyroid hormone regulation may provide an opportunity to better understand the coexistence of PHPT and vitamin D deficiency.

Who the Included Studies Covered

This study examined recent developments in understanding the relationship between vitamin D and PHPT.

This review of existing literature examined the impact of vitamin D insufficiency and deficiency, including the impact on diagnosis of vitamin D insufficiency/deficiency, diagnosis and management of PHPT, and the impact on overall health.

How the Review Was Done

An evidence-based literature review was based on a PubMed search for research involving vitamin D and primary hyperparathyroidism, and evaluating existing research on vitamin D.

The PubMed search included English-language articles published between 1977 and 2008, with a focus on research and analysis completed between 2005 and the present.

The level of evidence was determined according to criteria proposed by Sackett et al. and the grade of recommendation according to the criteria proposed by Heinrich et al.

What Was Measured

Primary hyperparathyroidism (PHPT) is a disease of the endocrine system that can result in debility if not diagnosed.

PubMed files the paper under topics including Hyperparathyroidism, Primary, Vitamin D and Vitamin D Deficiency.

What This Means in Plain Language

This is a review of Vitamin D, K2, Magnesium and Zinc in people with hyperparathyroidism.

Results are reported in around 4 sentences of the abstract; we leave them to the paper itself rather than summarise them.

The publication is from 2009 (World journal of surgery), a journal based in United States.

More context: the Vitamin D, K2, Magnesium and Zinc compound page, Hyperparathyroidism research.

Our Notes on the Compound

Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.

Related Pages

Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.